{"DataElement":{"publicId":"6043014","version":"1","preferredName":"Medical Contraindication Known Clinical Trial Eligibility Criteria Ind","preferredDefinition":"The indicator to determine eligibility for clinical trial participation for questions related to symptoms or medical conditions that make specific treatments or procedures inadvisable because a person is likely to have a bad reaction.","longName":"MED_CON_KNO_IND","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"6043013","version":"1","preferredName":"Medical Contraindication Known Clinical Trial Eligibility Criteria","preferredDefinition":"Any special symptom or circumstance that renders the use of a remedy or the carrying out of a procedure inadvisable, usually because of the risk._Recognized, familiar, or within the scope of knowledge._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"6043010v1.0:6043011v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"6043010","version":"1","preferredName":"Medical Contraindication","preferredDefinition":"Any special symptom or circumstance that renders the use of a remedy or the carrying out of a procedure inadvisable, usually because of the risk.","longName":"C50646","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medical Contraindication","conceptCode":"C50646","definition":"A symptom or medical condition that makes a particular treatment or procedure inadvisable because a person is likely to have a bad reaction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6061FFA3-46AE-62FF-E053-F662850A39E8","latestVersionIndicator":"Yes","beginDate":"2017-12-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-15","modifiedBy":"ONEDATA","dateModified":"2017-12-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6043011","version":"1","preferredName":"Known Clinical Trial Eligibility Criteria","preferredDefinition":"Recognized, familiar, or within the scope of knowledge.:Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"C80137:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Known","conceptCode":"C80137","definition":"Recognized, familiar, or within the scope of knowledge.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6061FFA3-46BF-62FF-E053-F662850A39E8","latestVersionIndicator":"Yes","beginDate":"2017-12-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-15","modifiedBy":"ONEDATA","dateModified":"2017-12-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6061FFA3-46D0-62FF-E053-F662850A39E8","latestVersionIndicator":"Yes","beginDate":"2017-12-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-15","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeDescription":"11/15/18 tt released. 12/15/17 tt/EAE161.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"10000277","version":"1","longName":"Eligibility","context":"ECOG-ACRIN"}]},{"publicId":"6162769","version":"1","longName":"University of Rochester","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6337044","version":"1","longName":"URCC Forms","context":"NCIP"}]}],"AlternateNames":[{"name":"IE_IEORRES_RADPROSTRT","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"Does the patient have known c","type":"Preferred Question Text","description":"Does the patient have known contraindications to bevacizumab, including but not limited to abdominal fistula, GI perforation, intra-abdominal abscess, thrombotic or hemorrhagic disorders, uncontrolled hypertension or active clinically significant cardiovascular disease, non-healing wound, ulcer, or bone fracture within 4 weeks prior to registration?","url":null,"context":"ECOG-ACRIN"},{"name":"URCC22063","type":"Alternate Question Text","description":"Have contraindications to physical function assessments (30-second arm curl, Timed-Up-And-Go test, or 30-second chair-stand test) per the treating provider or their designee.","url":null,"context":"NCIP"},{"name":"CCTG_01","type":"Alternate Question Text","description":"Participant has a contraindication for radical prostate radiotherapy (e.g., connective tissue disease or inflammatory bowel disease).","url":null,"context":"CCTG"}],"origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6060368C-F330-62E8-E053-F662850AF0CF","latestVersionIndicator":"Yes","beginDate":"2017-12-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-15","modifiedBy":"CLOHNES","dateModified":"2023-11-16","changeDescription":"11/15/18 tt released. 12/15/17 tt/EAE161.","administrativeNotes":"11/16/23 Added alt OID and AQT for CCTG ticket number CADSR0003085 cjl; 9/18/23 Added CSI and AQT per URMC ticket request CADSR0002862 cjl.","unresolvedIssues":null,"deletedIndicator":"No"}}